This will get to what you're referring to.
I think it's really important to understand that the original intent of the PMPRB was to prevent abuse of excessive prices, and what's happening here goes well beyond this. Our concern is that the guidelines create a great deal of uncertainty, which will prevent life-saving medications from coming to Canada. It is in the jurisdiction of the provinces to negotiate prices. The way the process works now, the pCPA, which is an alliance of provinces, negotiates with companies like ours based on the value that's assigned to a drug, based on an assessment of experts, and then—